Company Description

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting.

The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection.

The company was incorporated in 2015 and is based in Santa Clara, California.

HeartBeam, Inc.

Country	United States
Founded	2015
IPO Date	Nov 11, 2021
Industry	Health Information Services
Sector	Healthcare
Employees	15
CEO	Robert Eno

Contact Details

Address: 2118 Walsh Avenue, Suite 210 Santa Clara, California 95050 United States
Phone	408 899 4443
Website	heartbeam.com

Stock Details

Ticker Symbol	BEAT
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
IPO Price	$6.00
CIK Code	0001779372
CUSIP Number	42238H108
ISIN Number	US42238H1086
Employer ID	47-4881450
SIC Code	3841

Key Executives

Name	Position
Robert P. Eno	Chief Executive Officer and Chief Business Officer
Richard M. Ferrari	Executive Chairman
Dr. Branislav Vajdic Ph.D.	Founder, President and Director
Kenneth Persen	Chief Technology Officer
Timothy Cruickshank	Chief Financial Officer
Dr. Peter J. Fitzgerald FACC, M.D., Ph.D.	Member of Scientific Advisory Board and Chief Medical Officer
Richa Gujarati	Senior Vice President of Product

Latest SEC Filings

Date	Type	Title
Nov 7, 2024	10-Q	Quarterly Report
Oct 23, 2024	8-K	Current Report
Sep 10, 2024	8-K	Current Report
Aug 14, 2024	10-Q	Quarterly Report
Jun 18, 2024	8-K	Current Report
May 9, 2024	10-Q	Quarterly Report
May 3, 2024	424B5	Filing
May 2, 2024	8-K	Current Report
Apr 30, 2024	DEF 14A	Other definitive proxy statements
Apr 19, 2024	PRE 14A	Other preliminary proxy statements

View All SEC Filings